![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 47/38 | (2006.01) |
A61K 31/57 | (2006.01) | ||
A61K 31/565 | (2006.01) | ||
A61P 15/18 | (2006.01) |
(11) | Number of the document | 2217243 |
(13) | Kind of document | T |
(96) | European patent application number | 08847408.5 |
Date of filing the European patent application | 2008-10-22 | |
(97) | Date of publication of the European application | 2010-08-18 |
(45) | Date of publication and mention of the grant of the patent | 2014-08-06 |
(46) | Date of publication of the claims translation | 2014-11-25 |
(86) | Number | PCT/EP2008/008900 |
Date | 2008-10-22 |
(87) | Number | WO 2009/059690 |
Date | 2009-05-14 |
(30) | Number | Date | Country code |
07021465 | 2007-11-05 | EP |
(72) |
FRICKE, Sabine, DE
PFEIFER, Manuela, DE
CLAUSSEN, Claus, DE
LADWIG, Ralf, DE
BÜRGLEN, Beate, DE
|
(73) |
Bayer Pharma Aktiengesellschaft,
Müllerstrasse 178, 13353 Berlin,
DE
|
(74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
(54) | Gestagenas derinyje su estrogenu ir vienu arba keliais farmaciniu požiūriu toleruojamais ekscipientais / nešikliais belaktozinei peroralinei kontracepcijai |
GESTAGEN IN COMBINATION WITH AN ESTROGEN AND ONE OR MORE PHARMACEUTICALLY TOLERABLE EXCIPIENTS/CARRIERS FOR LACTOSE-FREE ORAL CONTRACEPTIVE |
Payment date | Validity (years) | Amount | |
2024-09-19 | 17 | 347.00 EUR |
2025-10-22 |